Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Templeton Apus is an Austrian digital media and intelligence company that developed the Templeton Apus - Universal (TA-U) specialist news and intelligence platform. Its coverage spans dozens of industries, including healthcare and pharmaceuticals, and it launched the Cancer Stat service in 2019 to provide cancer patients and healthcare professionals with real-time news, clinical trial updates, and treatment intelligence. The business appears to have operated as a commercial information-services company rather than a therapeutic drug developer. Available sources indicate a relationship with Krixos GmbH as a parent or holding company. While historical startup databases describe the company as active, registry aggregators also list Templeton Apus GmbH as being in liquidation, so current operating status appears uncertain and likely inactive as a standalone operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Templeton Apus.